Engine X Life Sciences

Engine X aims to improve the quality of life for people who are -- despite scientific advances -- dying to know better health.

Standardized language, common knowledge, conventional methods and systems comprising applied Medical sciences remain constrained by faulty framing. Whether its repetition of outdated Germ Theory, epidemiological elitism or social determinism, biomedical sciences, data, and statistical models today remain grounded in conventions from the 18'th Century Age of Enlightenment, but amplified by the power of global product purveyors, media and markets.

We see an untapped potential to more effectively address complex human factors and adaptation using Real World Data and emerging technology.  Our work combines systems-savvy capacity for whole perspectives on science, knowledge integration and translation in the epigenetic era of cellular and molecular Systems Biology. Computer-based decision systems have yet to address scale-free causal networks including disease with health. 

Business has spanned professional advisory services, contract research, and development of White Papers, products, programs, and systems. Our services are designed to deliver low-risk and highly cost-effective resources with and for self-caring individuals, thought- and practice-leaders and organizations.

Proprietary research over a decade has provided useful perspectives on causative considerations and formulations. Our own investments focus on person-centered health promotion, discovery and innovation:

CoherenceClinic [tm]

Precise Insights for Lasting Health

Assessment-led practice gives people a comprehensive handle on their own health. Combining whole person case study with novel electromagnetic assessment and biometry.

ex Life Sciences [tm]
Pre-clinical Discovery in Full Context
Cross-correlating all reports about the most pervasive microbial causes of disease amidst change in Allopathic Burden. Not only finding predictive algorithms to prevent major Disease diagnoses. Revealing low cost candidates for safe treatment of chronic idiopathy. These include targeted use of micro-nutrients, Cannabinoids and repurposed medications.    

Insights at all levels are relevant to public health policy, development of effective diagnostic protocols and therapeutic formulations of probable value in a range of major applications including novel Caronavirus.